DOCS — Dr Martens Cashflow Statement
0.000.00%
- £791.01m
- £1.04bn
- £787.60m
- 88
- 47
- 80
- 87
Annual cashflow statement for Dr Martens, fiscal year end - March 30th, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 52 W |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 35.7 | 181 | 129 | 69.2 | 4.5 |
Depreciation | |||||
Non-Cash Items | 49.3 | 17 | 28 | 37.7 | 38.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 40.2 | -50.7 | -138 | -11.3 | 76.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 160 | 184 | 77.3 | 168 | 196 |
Capital Expenditures | -18.6 | -25 | -51.4 | -28.4 | -18.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.8 | 2.9 | 3.4 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -18.6 | -25 | -50.6 | -25.5 | -15.3 |
Financing Cash Flow Items | -12.8 | -10.8 | -12 | -34 | -42.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -133 | -47 | -99.5 | -186 | -134 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.6 | 114 | -70.5 | -46.4 | 44.8 |